Skip to main content

Published locations for Crohn's disease: Ustekinumab more effective than vedolizumab in patients refractory to anti-TNF therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Crohn's disease: Ustekinumab more effective than vedolizumab in patients refractory to anti-TNF therapy

User login

  • Reset your password
  • /content/crohns-disease-ustekinumab-more-effective-vedolizumab-patients-refractory-anti-tnf-therapy
  • /gihepnews/article/241593/ibd-intestinal-disorders/crohns-disease-ustekinumab-more-effective